Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
nUNertmh60Wuu5DG
